Search
RISE logo

Björn Platzack

Enhetschef

Tel +46 10 516 63 83

Email bjorn.platzack@ri.se

Location Södertälje

Unit Kemisk och farmaceutisk toxikologi (101306)

Related

Expertise

ADME in silco, in vitro och in vivo

Pharmacokinetic (PK) studies are performed in order to optimize the absorption, distribution, metabolism and excretion (ADME) properties of molecules in the discovery phase of drug development. The results also provide a solid sci…
Expertise

Toxicology guidance and nonclinical safety assessment

Our toxicologists will design your safety assessment strategy and progress your drug from target evaluation to initial human clinical trials.
Expertise

Pharmaceutical Development

At RISE we know the entire pharmaceutical development chain, from target to patient. We can help with process development, analysis (GMP/GLP), formulation and production (GMP) of the pharmaceutical product for clinical trials, but…
Expertise

Toxicological evaluation

<p>New chemicals and pharmaceuticals must be safe for both humans and environments. Necessary knowledge can be generated and evaluated in a manner that considers time as well as economical and ethical factors.</p>
Expertise

Nanotechnology

The extremely small length scale of nanomaterials (below 100 nm) results in unique properties, such as optical, electronic, mechanical and magnetic properties. RISE offer a wide range of expertise to help you enable those unique p…